New, revolutionary sugar sweetens options for diabetics

'Sugir,’ real sugar that contains an additive to control sugar absorption, will now be added to popular breads, cereals to reduce the obesity epidemic
(PR NewsChannel) / November 2, 2011 / TAMPA, Fla. 
Sugir with Emulin
Sugir with Emulin

A diabetic-friendly sugar that has been proven to help reduce sugar intake will be added to popular breads and cereals to combat the rise of obesity in the United States, especially in children.

‘Sugir’ is real sugar that contains an all-natural additive called Emulin.  Studies have shown that Emulin blocks the absorption of sugar by more than 30 percent. Emulin™ is a patented formulation of compounds found in fruits, like grapefruits and berries.

“Sugar is not the problem, but rather how much sugar we consume,” Daryl Thompson, president of ATM Metabolics, the research firm that discovered Emulin, says. “By adding this natural compound of Emulin to sugar, Sugir now has the power to reverse diabetes.”

A new independent study conducted in Winter Haven, Fla. found that a group of overweight yet otherwise healthy individuals lost an average of seven pounds by doing nothing more than adding Emulin to their diets.

The independent study, “Effect of Emulin™ on Weight Loss,” was conducted by Dr. Dale Wickstrom-Hill, the director of Perfect Form Weight Loss Clinic, LLC.

The study’s conclusion: “Emulin can assist with weight loss in obese individuals without change in dietary intake.”

Daryl Thompson and Joe Ahrens, president and vice-president of ATM Metabolics
Daryl Thompson and Joe Ahrens, president and vice-president of ATM Metabolics

Emulin has been available online and at GNC stores. But in the coming weeks, Winter Haven, Fla.-based ATM Metabolics says Emulin will be added to popular breads and cereals.

“By having Emulin in the food supply, we will see a rapid reduction in obesity and diabetes rates,” Dr. Joseph Ahrens, vice-president of ATM Metabolics says. “Much like what folate in breads did for birth defect rates, Emulin will be able to do the same for obesity and diabetes rates, which continue to skyrocket in the United States.”

ATM Metabolics says that Emulin slows the conversion of complex carbohydrates to simple sugars as well as reduces sugar absorption from the gut to the bloodstream while stimulating absorption from the bloodstream to muscle tissue.

The Study:

The 24 participants were split into two groups; one half received Emulin while the other received a placebo, but both groups received 250 mg capsules three times a day. Participants were not required to change their diets or exercise routine, just simply take the capsules three times a day.

Participants were weighed and measured in the chest, waist, hips and thigh areas before starting the study and every week throughout. Medical professionals also measured their blood pressure, respiration, pulse, body mass index and fat percentage.

After one month of taking Emulin, the 12 participants saw an average loss of seven pounds as well as decrease in their body fat percentage. As for their measurements, the group had lost over 7 inches in the chest area, 6.9 inches in the waist, 8 inches in the hips region and just over 4 inches on their thighs.

The leading weight loss drug Alli is reported to help individuals lose five to seven pounds a year with proper diet and exercise. Emulin showed similar results in simply 30 days without negative side effects commonly associated with Alli.

Participants’ blood pressure, respiration and pulse were all measured, but there was no change in any of these vitals due to Emulin’s all-natural composition.

“This study not only shows that Emulin helps in the fight against obesity, but it also shows that it doesn’t adversely affect the body,” Ahrens says. “Emulin works with the body’s natural mechanisms to manage sugar, rather than against them, like many weight loss supplements.”

About ATM Metabolics: ATM Metabolics is a research firm focused on returning to the origins of drug discovery by exploring the metabolic and physiological pathways of plants in an effort to better understand how these unique systems may offer us clues to creating better and safer therapeutics. They are dedicated to the discovery of new and useful treatments for metabolic and neurological disorders.

MEDIA CONTACT
Glenn Selig
PR firm: The Publicity Agency
Email: Phone: (813) 708-1220

Jessica Pajak
PR firm: The Publicity Agency
Email: Phone: (813) 708-1220 x7782

Direct link:  https://prnewschannel.com/2011/11/02/new-revolutionary-sugar-sweetens-options-for-diabetics-2/

SOURCE:  The Publicity Agency

Print FriendlyPrint Friendly

This press release is distributed by PR NewsChannel. Your News. Everywhere.